PHAC: COVID-19 Variants and Vaccines

Introduction

This webinar will inform health care providers on national surveillance measures and effects of vaccines on variants internationally and in Canada.

The National Collaborating Centre for Infectious Diseases presents:

A Public Health Agency of Canada (PHAC) COVID-19 Vaccines Webinar for Health Care Providers (HCPs) to inform HCPs and vaccine providers on COVID-19 vaccine discussion topics.

This moderated webinar includes a presentation and discussion with live Q&A to inform health care and vaccine providers on the national surveillance for COVID-19 variants of concern (VOCs), vaccine efficacy and effectiveness against VOCs, and the impact of vaccines and variants in Canada. 

Resources

English Presentation

Wednesday, June 23, 2021

12pm-1pm EDT

Key objectives: 

  • Identify the national surveillance systems that detect and track SARS-CoV2 variants, including variants of concern (VOCs), in Canada
  • Discuss key findings on vaccine efficacy and effectiveness against VOCs, internationally and in Canada
  • Summarize how predictive epidemiological models can inform Canadian forecasts and response to SARS-CoV2

Moderator:

Dr. David Alexander, PhD, Assistant Professor, University of Manitoba, Max Rady College of Medicine, Department of Medical Microbiology & Infectious Diseases

Presenters:

Dr. Gary Van Domselaar, PhD, Head Bioinformatics, National Microbiology Laboratory, Public Health Agency of Canada

Dr. Victoria Ng, PhD, Senior Scientist, Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada

Eva Wong, MPH, Senior Epidemiologist, Public Health Agency of Canada 

Lindsay Whitmore, MHSc, Manager COVID-19 Epidemiology and Surveillance, Public Health Agency of Canada